| Cash Flow | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net loss | -5,512,411 | 4,107,334 | NaN |
| Stock-based compensation | -3,485 | 0 | 3,485 |
| Net loss | NaN | NaN | -2,871,400 |
| Amortization of intangible assets | -63,523 | 92,378 | NaN |
| Prepaids and other current assets | NaN | -52,557 | -105,114 |
| Amortization of note receivable premium | -3,627 | NaN | NaN |
| Inventory | 1,200 | 0 | -1,200 |
| Prepaids and other current assets | -33,772 | NaN | NaN |
| Accounts payable | 49,138 | -16,291 | -10,080 |
| Amortization | NaN | NaN | 61,319 |
| Accrued expenses | 39,920 | 0 | -39,920 |
| Net cash used in operating activities | 2,595,581 | -1,168,609 | -2,750,282 |
| Redemptions of investments | NaN | 0 | NaN |
| Issuance of note receivable | 50,000 | NaN | NaN |
| Redemptions of investments | NaN | NaN | 0 |
| Payment of patent purchase obligation - related party | NaN | 0 | NaN |
| Investment in related entity | 125,000 | NaN | NaN |
| Net cash used in investing activities | -175,000 | 0 | 0 |
| Proceeds from exercise of warrants, net of issuance costs | NaN | 0 | 3,364,000 |
| Proceeds from sale of series b preferred stock | NaN | 0 | 0 |
| Contribution from minority member | 13,360 | NaN | NaN |
| Purchase of treasury stock | -10,000 | 0 | 10,000 |
| Proceeds from sale of common stock and warrants, net of issuance costs | 0 | NaN | NaN |
| Net cash provided in financing activities | -3,340,640 | 0 | 3,354,000 |
| Net change in cash | -920,059 | -1,168,609 | 603,718 |
| Beginning cash balance | 1,832,615 | 5,940,402 | NaN |
| Ending cash balance | 347,665 | 5,375,511 | NaN |
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)